2.2. Conditioning of Human Dermal Lymphatic Microvascular Endothelial Cells with Systemic Sclerosis Serum Significantly Downregulates Gene and Protein Expression of Pro-Lymphangiogenic VEGFR-3/Flt-4 and Its Co-receptor NRP-2. The gene discussed is FLT4; the disease is systemic sclerosis.